Skip to main content

Nanopore Sequencing Startup Nabsys Closes $4M Equity Round


Nabsys said today that it has closed a $4 million equity round, led by Point Judith Capital. The Slater Technology Fund and other previous investors also participated in the round.

The Providence, RI-based company said it will use the proceeds to further develop its nanopore-based DNA sequencing technology, which combines solid-state nanopores with sequencing-by-hybridization.

Originally, both approaches were independently pursued by researchers at Brown University, who founded two companies, Nabsys and GeneSpectrum. In late 2006, Nabsys acquired GeneSpectrum in an all-stock transaction (see In Sequence 1/9/2007).

The idea of the technology is to use electrically addressable nanoarrays to determine the position of probes hybridized to long fragments of DNA. By repeating the process with many probes from a library and comparing the hybridization patterns, the DNA sequence can be deduced.

Nabsys was founded in 2004 by Brown professors Xinsheng Sean Ling and Leon Cooper, and has exclusively licensed nanopore technology developed by Ling, a professor of physics.

In 2007, Nabsys won a two-year, $480,000 grant from the National Human Research Institute's Advanced Sequencing Technology program to develop its hybridization-assisted nanopore sequencing, or HANS, technology. Separately, Ling won a three-year, $820,000 grant under the same program that year to develop the technology.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.